Reforms urgently needed to streamline road to Alzheimer's
Wednesday, November 6, 2013 - 21:00
in Health & Medicine
As the burden of Alzheimer's disease escalates worldwide, efforts to develop effective treatments are failing to keep pace because of the high costs and risks associated with developing Alzheimer's drugs. Reforming Alzheimer's drug development, so it is more streamlined and efficient, would bring down costs and speed progress toward approval of drugs that slow or stop the disease.